Silvius Stanciu | Biology and Life Sciences | Innovative Research Award

Innovative Research Award

Silvius Stanciu
“Dunarea de Jos” University of Galati, Romania

Silvius Stanciu
Affiliation “Dunarea de Jos” University of Galati
Country Romania
Scopus ID 57202534648
Documents 118
Citations 639
h-index 13
Subject Area Biology and Life Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0001-7697-0968

The Innovative Research Award recognizes scholarly achievement and interdisciplinary scientific contribution within the fields of biology, agricultural sustainability, environmental systems, and food sciences. The academic profile of Silvius Stanciu demonstrates sustained engagement in applied scientific research, particularly in environmental monitoring, agricultural development, renewable energy systems, and sustainability-oriented technological integration.[1] His publication record reflects a multidisciplinary approach connecting ecological analysis, agricultural economics, and technological innovation across regional and international contexts.[2]

Abstract

Silvius Stanciu has contributed to research concerning agricultural sustainability, environmental monitoring, food systems, and renewable energy assessment. His work incorporates data-driven methodologies, GIS-based environmental analysis, and policy-oriented agricultural studies aimed at supporting sustainable regional development.[3] The diversity of publications demonstrates engagement with interdisciplinary scientific frameworks relevant to biology and life sciences. Current studies emphasize riverbank stability, agricultural productivity, food event analysis, and climate-related agricultural trends in Romania.[4]

Keywords

Agricultural sustainability, GIS applications, renewable energy, environmental monitoring, food systems, biology and life sciences, climate analysis, technological innovation, agricultural economics, riverbank stability.

Introduction

Research within biology and life sciences increasingly integrates environmental sciences, computational analysis, and sustainability-oriented methodologies. Silvius Stanciu’s scholarly profile aligns with these contemporary academic directions through studies focused on agricultural systems, environmental risk evaluation, and regional sustainability planning.[2] His investigations into agro-food technology transfer and renewable energy uncertainties contribute to applied scientific discourse associated with climate resilience and ecological management.

Research Profile

The researcher has produced a substantial body of scholarly literature indexed through Scopus and related academic databases. His profile includes journal articles, interdisciplinary analyses, and technology-focused publications involving environmental sustainability and agricultural development. Academic output spans food systems research, renewable energy evaluation, and climate-related agricultural productivity studies.[5]

Research Contributions

  • Development of GIS-based approaches for monitoring heavy metal contamination in water systems.
  • Analysis of agricultural land-use changes affecting Danube River stability and inland navigation systems.
  • Macro-level climatic analysis of cereal productivity integrating precipitation datasets and crop statistics.
  • Research on sustainability perceptions among farm holders and agricultural stakeholders.
  • Evaluation of Romania’s renewable energy investment uncertainties using data-driven methodologies.

Publications

  • Estimating the Impact of Agricultural Land-Use–Land-Cover Change on Riverbank Stability and Critical Inland Navigation Areas of the Danube River, Earth, 2026.
  • GIS Applications in Monitoring and Managing Heavy Metal Contamination of Water Resources, Applied Sciences, 2025.
  • Data–driven analysis of Romania’s renewable energy landscape and investment uncertainties, Heliyon, 2024.

Research Impact

The research impact associated with Silvius Stanciu is reflected through interdisciplinary citation activity and publication diversity across sustainability, environmental management, and food systems studies. His research provides analytical frameworks applicable to policy development, agricultural modernization, and environmental protection strategies. The integration of technological tools such as GIS and climate datasets further strengthens the applied significance of his scientific contributions.[6]

Award Suitability

The Innovative Research Award is suitable for recognizing contributions that integrate scientific innovation with practical societal relevance. Silvius Stanciu’s work demonstrates interdisciplinary engagement connecting agricultural systems, ecological sustainability, and technological analysis. The consistent publication activity and measurable scholarly metrics support recognition within the framework of international innovation-oriented academic awards.[1]

Conclusion

Silvius Stanciu’s academic record reflects sustained participation in multidisciplinary scientific research addressing environmental sustainability, agricultural resilience, and technological advancement. His publication profile, citation performance, and ongoing research activities support recognition through the Innovative Research Award within the Global Innovation Technologist Awards framework.

References

  1. Elsevier. (n.d.). Scopus author details: Silvius Stanciu, Author ID 57202534648. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57202534648
  2. Heliyon. (2024). Data–driven analysis of Romania’s renewable energy landscape and investment uncertainties.
    https://doi.org/10.1016/j.heliyon.2024.e27334
  3. Applied Sciences. (2025). GIS Applications in Monitoring and Managing Heavy Metal Contamination of Water Resources.
    https://doi.org/10.3390/app151910332
  4. Earth. (2026). Estimating the Impact of Agricultural Land-Use–Land-Cover Change on Riverbank Stability and Critical Inland Navigation Areas of the Danube River.
    https://doi.org/10.3390/earth7030085
  5. Romanian Agricultural Research. (2026). Climatic Drivers of Cereal Productivity in Romania (1997-2024): a Macro-Level Analysis Integrating Era5 Precipitation Data and National Crop Statistics.
    https://doi.org/10.59665/rar4329
  6. Frontiers in Sustainable Food Systems. (2025). Food events from the perspective of visitors and vendors. Case study: the “Iasul în Bucate” fair, Romania.
    https://doi.org/10.3389/FSUFS.2025.1638523

Bruce Liang | Biology and Life Sciences | Innovative Research Award

Innovative Research Award

Bruce Liang
University of Connecticut Health Center, United States
Bruce Liang
Affiliation University of Connecticut Health Center
Country United States
Scopus ID 7202071205
Documents 115
Citations 5,181
h-index 42
Subject Area Biology and Life Sciences
Event Global Innovation Technologist Awards

The Innovative Research Award recognizes distinguished scholarly contributions and sustained scientific advancement within the field of Biology and Life Sciences. Bruce Liang of the University of Connecticut Health Center has established a notable academic profile through extensive research output, interdisciplinary biomedical investigations, and influential publications focused on cardiovascular biology, ischemic injury, receptor pharmacology, and translational medicine.[1] His body of work reflects ongoing engagement with contemporary biomedical challenges and emerging therapeutic methodologies relevant to modern clinical research.[2]

Abstract

Bruce Liang has contributed extensively to biomedical and translational research through investigations involving cardiovascular disease mechanisms, ischemic stroke biology, receptor-mediated signaling, and molecular therapeutics.[1] His publication record demonstrates a multidisciplinary approach integrating molecular biology, pharmacology, artificial intelligence applications in healthcare, and experimental cardiovascular medicine.[3] With 115 indexed scholarly documents and more than 5,181 citations recorded in Scopus, Liang’s research profile reflects sustained academic engagement and measurable scientific influence within the biomedical sciences.[1]

Keywords

Cardiovascular biology; ischemic stroke; receptor pharmacology; translational medicine; molecular therapeutics; purinergic signaling; biomedical innovation; multi-omics; artificial intelligence in medicine; targeted drug delivery; cardiovascular disease biomarkers; Biology and Life Sciences.

Introduction

Contemporary biomedical research increasingly relies on interdisciplinary methodologies capable of bridging molecular science, clinical application, and computational analysis. Bruce Liang has participated in this evolving landscape through contributions to cardiovascular and neurological research, particularly in the study of ischemia, receptor signaling pathways, inflammatory regulation, and therapeutic intervention strategies.[4] His recent publications further demonstrate interest in artificial intelligence and multi-omics approaches for disease biomarker discovery and predictive modeling within cardiovascular medicine.[5]

The breadth of Liang’s research activities reflects a combination of experimental biology, translational pharmacology, and collaborative scientific inquiry. His citation metrics and publication volume indicate substantial academic engagement within peer-reviewed biomedical literature.[1]

Research Profile

Bruce Liang is affiliated with the University of Connecticut Health Center in Farmington, United States, where his research activities are associated with cardiovascular medicine, translational therapeutics, and molecular biology.[1] His Scopus profile records 115 scholarly documents and an h-index of 42, indicating a sustained citation presence and broad dissemination of his scientific work.[1]

His research output spans several interconnected biomedical domains, including:

  • Cardiovascular disease mechanisms and molecular signaling pathways.
  • Ischemic stroke pathophysiology and neurovascular regulation.
  • AI and machine learning applications for biomarker discovery.

Research Contributions

Liang’s recent scientific contributions include investigations into P2X4 receptor signaling and ischemia/reperfusion injury in murine models.[6] His work has examined molecular mechanisms associated with cardiovascular dysfunction, inflammatory signaling, and neurovascular injury progression.[7]

A significant aspect of his recent scholarship involves the integration of multimodal artificial intelligence and machine learning methodologies for identifying novel cardiovascular disease biomarkers using multi-omics datasets.[5] These investigations contribute to ongoing efforts toward precision medicine and predictive diagnostics in clinical healthcare systems.

Publications

Selected recent publications associated with Bruce Liang include the following peer-reviewed articles:

  1. Novel P2X4 Receptor Antagonist MRS4719 Improves Ischemia/Reperfusion Injury in Mice, Medicinal Chemistry Research, 2026.
  2. TRPM2 Overactivation Drives Hyperlipidemia-Induced Dysfunction of Myeloid Cells and Neurovascular Units, Cell Reports Medicine, 2025.
  3. Multimodal AI/ML for Discovering Novel Biomarkers and Predicting Disease Using Multi-Omics Profiles of Patients with Cardiovascular Diseases, Scientific Reports, 2024.
  4. Revealing the Novel Role of Purinergic Receptor P2X4 in Phagocytic Uptake After Ischemic Stroke, Journal of the American Heart Association, 2024.
  5. Fluorescent Liposomal Nanocarriers for Targeted Drug Delivery in Ischemic Stroke Therapy, Biomaterials Science, 2023.

Research Impact

The citation record associated with Liang’s research profile indicates broad academic visibility within biomedical and translational science literature.[1] His work contributes to ongoing scientific discussions concerning cardiovascular pathology, neurovascular injury, receptor signaling, and precision medicine approaches.[5]

The interdisciplinary nature of his publications demonstrates collaboration across molecular biology, pharmacology, computational analysis, and clinical medicine. This breadth of scholarship is relevant to both laboratory-based investigations and translational healthcare research initiatives.[3]

Award Suitability

Bruce Liang’s research profile aligns with the objectives of the Global Innovation Technologist Awards through sustained scientific productivity, interdisciplinary biomedical investigation, and contributions to translational healthcare research.[1] His publication history demonstrates continued engagement with emerging scientific methodologies including multi-omics analytics, artificial intelligence-assisted disease modeling, and receptor-targeted therapeutics.[5]

The combination of citation influence, peer-reviewed scholarship, and translational research applications supports the relevance of his academic profile for recognition within innovation-oriented scientific award programs.[2]

Conclusion

Bruce Liang has developed an established research portfolio within Biology and Life Sciences through extensive scholarly publication, interdisciplinary biomedical collaboration, and investigations into cardiovascular and neurovascular disease mechanisms. His work reflects sustained participation in translational medicine, receptor biology, and computational healthcare research. The documented citation impact and continued publication activity indicate ongoing scientific engagement relevant to modern biomedical innovation and academic recognition initiatives.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Bruce Tsan Tang Liang, Author ID 7202071205. Scopus.
    www.scopus.com/authid/detail.uri?authorId=7202071205
  2. Global Innovation Technologist Awards. (2026). Award recognition and innovation excellence overview.
    innovationtechnologist.com
  3. Scientific Reports. (2024). Multimodal AI/ML for discovering novel biomarkers and predicting disease using multi-omics profiles of patients with cardiovascular diseases.
  4. Journal of the American Heart Association. (2024). Revealing the Novel Role of Purinergic Receptor P2X4 in Phagocytic Uptake After Ischemic Stroke.
  5. Nature Portfolio. (2024). Artificial intelligence and multi-omics approaches in cardiovascular disease prediction.
  6. Medicinal Chemistry Research. (2026). Novel P2X4 Receptor Antagonist MRS4719 Improves Ischemia/Reperfusion Injury in Mice.
  7. Cell Reports Medicine. (2025). TRPM2 Overactivation Drives Hyperlipidemia-Induced Dysfunction of Myeloid Cells and Neurovascular Units.

Arif Uddin | Zoology | Editorial Board Member

Dr. Arif Uddin | Zoology | Editorial Board Member

Assistant Professor at Moinul Hoque Choudhury Memorial Science College | India

Dr. Arif Uddin is a distinguished researcher and academician in the field of zoology with a strong interdisciplinary focus spanning molecular biology, molecular neurobiology, cancer biology, and mitochondrial DNA research. His scientific contributions reflect a deep interest in understanding nucleotide composition, codon usage dynamics, molecular evolution, and gene regulation across diverse organisms, including humans, animals, plants, viruses, and mitochondrial systems. With an extensive body of work comprising more than seventy research publications and over two thousand citations, he has significantly advanced knowledge in areas such as disease-associated gene characterization, mitochondrial genomics, neurodegenerative disorders, oncology-related molecular signatures, and comparative genomics. Dr. Uddin’s research frequently integrates bioinformatics, molecular genetics, and computational biology to explore codon usage patterns, evolutionary forces, expression levels, and genome-wide compositional features. His contributions have earned him multiple recognitions, fellowships, and invitations to review for reputed scientific journals and international foundations. He has also been acknowledged for publishing widely read and highly downloaded papers in leading journals. Alongside his research, he has taught a broad range of zoology and life science subjects, enriching academic environments through his expertise. Dr. Uddin continues to contribute meaningfully to both scientific research and higher education through dedicated scholarship and active engagement in the global research community.

Profile: Scopus | Orcid | Google Scholar

Featured Publications

Malakar, S. C. A. K., Choudhury, D., Halder, B., Paul, P., Chakraborty, S., & Uddin, A. (2019). A review on coronary artery disease, its risk factors, and therapeutics. Journal of Cellular Physiology, 1437.

Deb, B., Uddin, A., & Chakraborty, S. (2018). miRNAs and ovarian cancer: An overview. Journal of Cellular Physiology, 233(5), 3846–3854.

Chakraborty, S., Yengkhom, S., & Uddin, A. (2020). Analysis of codon usage bias of chloroplast genes in Oryza species: Codon usage of chloroplast genes in Oryza species. Planta, 252(4), 67.

Deb, B., Uddin, A., & Chakraborty, S. (2020). Codon usage pattern and its influencing factors in different genomes of hepadnaviruses. Archives of Virology, 165(3), 557–570.

Uddin, S. C. A., & Mazumder, T. H. (2018). Understanding molecular biology of codon usage in mitochondrial complex IV genes of electron transport system: Relevance to mitochondrial diseases. Journal of Cellular Physiology, 53.

Sara Carloni | Biology and Life Sciences | Best Researcher Award

Assist. Prof. Dr. Sara Carloni | Biology and Life Sciences | Best Researcher Award

Assistant Professor at Humanitas University, Italy

Dr. Sara Carloni is an Assistant Professor of Microbiology and Clinical Microbiology at Humanitas University, Italy. Her career spans over a decade of cutting-edge research into microbial pathogenesis, microbiota-host interactions, the gut-brain axis, and antimicrobial resistance (AMR). A pivotal figure in translational microbiology, Dr. Carloni has contributed substantially to both experimental and clinical microbiology. Her breakthrough discovery of a choroid plexus vascular barrier associated with intestinal inflammation, published in Science (2021), has positioned her as a global leader in microbiota and neuroinflammation studies. As a corresponding or leading author on multiple high-impact publications and a frequent speaker at international conferences, she continues to influence the future of biomedical sciences.

Publication Profile 

Scopus

Orcid

Educational Background 🎓

Dr. Sara Carloni has cultivated a robust academic foundation in microbiology and biotechnology through progressive and interdisciplinary training across prestigious institutions. She earned her Bachelor’s degree in Industrial and Environmental Biotechnologies in 2009 from a joint program between Università degli Studi di Milano and Universitat Rovira i Virgili in Spain. She then completed her Master’s degree in Biotechnology at Università degli Studi di Milano in July 2011. Driven by a keen interest in microbial research, she pursued a Ph.D. in Biological and Molecular Sciences with a specialization in Molecular Microbiology, which she completed in May 2015 at Università degli Studi di Milano. Following her doctorate, she engaged in several postdoctoral fellowships: first at Università degli Studi di Milano (2015), focusing on small RNA-mediated mechanisms in Pseudomonas aeruginosa; then at the European Institute of Oncology (2016–2017), investigating microbiota in intestinal and oncologic disorders; and subsequently at Humanitas University (2018–2021), where she delved into the gut-brain axis and intestinal inflammation. Her academic journey culminated in her appointment as Assistant Professor of Microbiology and Clinical Microbiology (RTDA) at Humanitas University in 2021.

Professional Experience 💼

  • Assistant Professor (RTDA)
    Humanitas University (2021–Present)

    • Teaching and research in Microbiology and Clinical Microbiology (MED/07)

    • Supervising PhD and MD students; leading microbiota and AMR research units

  • Postdoctoral Fellow
    Humanitas University (2018–2021)

    • Investigated gut-brain axis, choroid plexus, and intestinal inflammation

  • Postdoctoral Fellow
    European Institute of Oncology (IEO) (2016–2017)

    • Microbiota in IBD and tumorigenesis; explored colitis-brain interaction

  • Postdoctoral Fellow
    Università degli Studi di Milano (2015)

    • Studied quorum sensing and small RNAs in Pseudomonas aeruginosa

Research Interests 🔬

  • Gut-Brain Axis (GBA) and Vascular Barriers

  • Antimicrobial Resistance (AMR)

  • Host-Microbiota Interactions

  • Microbial Metabolites and Neuroinflammation

  • Translational Microbiology

  • Bacterial Extracellular Vesicles (bEVs)

  • Artificial Intelligence in Microbial Diagnostics

Awards and Honors🏆✨

  • Invited Speaker at premier international conferences including:

    • Digestive Disease Week (2024)

    • ECCO Congress (2024)

    • Potsdam Symposium on Mucosal Immunology (2023)

    • IFHNOS World Congress Moderator (2023)

  • Leader of research units in:

    • PNRR-INF-ACT (One Health & AMR Surveillance)

    • PNRR-NBFC (Human Wellbeing & Microbial Biodiversity)

    • 5X1000 Humanitas (IBD and Psychiatric Comorbidities)

  • Visiting Professor, Institut Pasteur – Leadership in microbiota-host interaction and bEVs research

Conclusion🌟

Dr. Sara Carloni stands out as an innovative and collaborative microbiologist, contributing significantly to modern biomedical research. With over 19 peer-reviewed publications, an H-index of 11, and over 1200 citations, she merges basic science discoveries with clinical applications, particularly in AMR surveillance and gut-brain communication. Her multidisciplinary and translational approach places her at the forefront of microbiology, making her a strong contender for high-level research recognitions and global scientific leadership.

Publications 📚

  1. 🍼 Maternal gut microbiota influences immune activation at the maternal-fetal interface affecting pregnancy outcome
    🗞 Nature Communications
    📅 2025-05-09 | 🔗 DOI: 10.1038/s41467-025-58533-8
    👩‍🔬 Contributors: Silvia Giugliano, Andrea Gatti, Martina Rusin, Tilo Schorn, Silvia Pimazzoni, Michela Calanni-Pileri, Valentina Fraccascia, Sara Carloni, Maria Rescigno


  2. 🧫 Epidemiology and resistance profiles of bacteria isolated from blood samples in septic patients at emergency department admission: A 6-year single-centre retrospective analysis from Northern Italy
    🗞 Journal of Global Antimicrobial Resistance
    📅 2025-03 | 🔗 DOI: 10.1016/j.jgar.2024.12.023
    👩‍🔬 Contributors: Valeria Cento, Sara Carloni, Riccardo Sarti, et al.


  3. 🤰 Role of the maternal gut microbiota in immune activation at the maternal-fetal interface: Impact on preeclampsia
    📄 Preprint
    📅 2023-05-30 | 🔗 DOI: 10.21203/rs.3.rs-2845955/v1
    👩‍🔬 Contributors: Maria Rescigno, Silvia Giugliano, Sara Carloni, Tilo Schorn


  4. 🧠 Unveiling the gut-brain axis: Structural and functional analogies between the gut and the choroid plexus vascular and immune barriers
    🗞 Seminars in Immunopathology
    🔗 DOI: 10.1007/S00281-022-00955-3
    👩‍🔬 Contributors: Sara Carloni, Maria Rescigno


  5. 🦠 Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liver
    🗞 Cancer Cell
    🔗 DOI: 10.1016/j.ccell.2021.03.004
    👩‍🔬 Contributors: Bertocchi, A., Carloni, S., et al.


  6. 🧠 Identification of a choroid plexus vascular barrier closing during intestinal inflammation
    🗞 Science
    🔗 DOI: 10.1126/science.abc6108
    👩‍🔬 Contributors: Carloni, S., Bertocchi, A., et al.


  7. 🧪 SARS-CoV-2 serology in 4000 health care and administrative staff across seven sites in Lombardy, Italy
    🗞 Scientific Reports
    🔗 DOI: 10.1038/s41598-021-91773-4
    👩‍🔬 Contributors: Sandri, M.T., Carloni, S., et al.


  8. 🧫 Complement C3aR loss drives colorectal cancer by modulating gut microbiota
    🗞 Journal of Immunology
    🔗 WOS: WOS:000589972400485
    👩‍🔬 Contributors: Guglietta, Silvia, Carloni, Sara, et al.


  9. 🦠 Endogenous murine microbiota member Faecalibaculum rodentium and its human homologue protect from intestinal tumour growth
    🗞 Nature Microbiology
    🔗 DOI: 10.1038/s41564-019-0649-5
    👩‍🔬 Contributors: Zagato, E., Carloni, S., et al.


  10. 🧪 IgG serology in health care and administrative staff populations from 7 hospitals representative of different exposures to SARS-CoV-2 in Lombardy, Italy
    📄 medRxiv Preprint
    🔗 DOI: 10.1101/2020.05.24.20111245
    👩‍🔬 Contributors: Sandri, M.T., Carloni, S., et al.


  11. 💩 Therapeutic faecal microbiota transplantation controls intestinal inflammation through IL10 secretion by immune cells
    🗞 Nature Communications
    🔗 DOI: 10.1038/s41467-018-07359-8
    👩‍🔬 Contributors: Burrello, C., Carloni, S., et al.


  12. 🧬 The small RNA ReaL: A novel regulatory element embedded in the Pseudomonas aeruginosa quorum sensing networks
    🗞 Environmental Microbiology
    🔗 DOI: 10.1111/1462-2920.13886
    👩‍🔬 Contributors: Carloni, S., Macchi, R., et al.


  13. 🦠 Post-transcriptional regulation of the virulence-associated enzyme AlgC by the σ²²-dependent small RNA ErsA of Pseudomonas aeruginosa
    🗞 Environmental Microbiology
    🔗 DOI: 10.1111/1462-2920.12590
    👩‍🔬 Contributors: Ferrara, S., Carloni, S., et al.


 

 

 

 

Didi Chen | Biology | Best Researcher Award

Dr. Didi Chen | Biology | Best Researcher Award

Full-time teacher at Hubei University of Education, China

Dr. Didi Chen is a materials chemist and fluorescence imaging researcher affiliated with the School of Chemistry and Life Sciences, Hubei University of Education. His research primarily focuses on the design and development of fluorescent bioprobes based on Aggregation-Induced Emission (AIE) for biomedical applications such as tumor detection, intraoperative imaging, and biomarker quantification. With multiple publications in high-impact journals and a leading role in national-level research projects, Dr. Chen is contributing to the advancement of bioimaging technologies for real-time diagnostics and cancer surgery guidance.

Publication Profile 

Scopus

Educational Background 🎓

  • Ph.D. in Materials Science and Engineering
    Beijing Institute of Technology
    September 2013 – June 2017

  • Master’s Degree in Chemistry
    School of Chemistry, Central China Normal University
    September 2009 – June 2012

  • Bachelor’s Degree in Chemistry
    College of Chemistry, Central China Normal University
    September 2005 – June 2009

Professional Experience 💼

  • Faculty Member, School of Chemistry and Life Sciences, Hubei University of Education
    Engaged in teaching and research in materials chemistry and bioimaging.

  • Principal Investigator, National Natural Science Foundation of China (NSFC) Project for Young Scientists (Project No. 22405079)
    2025–2027: Project on real-time navigation of liver cancer surgery using AIE-based fluorescent probes.

  • Active contributor to multidisciplinary research projects in molecular design, bio-detection, and fluorescence-guided surgery.

Research Interests 🔬

  • Aggregation-Induced Emission (AIE) and its application in:

    • Fluorescent probe design

    • Bioimaging and surgical guidance

    • Tumor microenvironment studies

    • Biomolecular sensing (e.g., CO₂, HSA, FIB)

  • Intraoperative imaging techniques for early cancer diagnosis

  • Interaction studies between stromal and tumor cells using AIEgens

Awards and Honors🏆✨

  • Principal Investigator, National Natural Science Foundation of China for Young Scientists (2025–2027)

  • Recognition through peer-reviewed publications in top-tier journals such as Biomaterials, Analytica Chimica Acta, Materials Chemistry Frontiers, Sensors and Actuators B, and Aggregate.

Conclusion🌟

Dr. Didi Chen is an emerging leader in the field of fluorescent bio-probe development for cancer diagnostics and intraoperative applications. His work integrates innovative materials chemistry with real-world clinical challenges, contributing significantly to non-invasive imaging and tumor identification. He has demonstrated capability in acquiring competitive research funding, publishing impactful studies, and advancing knowledge at the interface of chemistry, biology, and medicine.

Given his strong academic background, successful grant leadership, and impactful publication record, Dr. Chen is well-positioned for continued contributions to translational biomedical research and qualifies as a strong candidate for research awards and honors in the fields of chemistry and medical diagnostics.

Publications 📚

1️⃣ 🧪 ND-TPE-COOH: Protein-activated fluorescent diagnostic probes for rapid identification and resection of liver tumors
👩‍🔬 Qu, J., Li, Z., Zhong, H., Mukerabigwi, J.F., Cao, Y.
📘 Sensors and Actuators B: Chemical, 2025
🔬 Focus: Development of a novel fluorescent probe for rapid liver tumor diagnosis and surgical assistance.


2️⃣ 🧬 Fluorescence-guided Surgery for Hepatocellular Carcinoma: From Clinical Practice to Laboratories
👨‍⚕️ Xiao, T., Chen, D., Peng, L., Zhang, J., Li, M.
📕 Review Article, 2025
📈 Citations: 2
💡 Scope: Bridging clinical application and lab development in fluorescence-guided liver cancer surgery.


3️⃣ 💡 The Fluorescent Bioprobe with Aggregation-Induced Emission Features for Monitoring Carbon Dioxide Generation in Single Living Cells
🔬 Chen, D., Wang, H., Dong, L., Liu, P., Zhang, Y., Shi, J., Feng, X., Zhi, J., Tong, B., Dong, Y.
📘 Biomaterials, 2016, 103: 67–74
🧫 Highlights: Real-time CO₂ tracking and early cancer cell detection using AIE-based probes.


4️⃣ 🧪 Two-Step Separation-Free Quantitative Detection of HSA and FIB in Human Plasma using an AIE Probe
🔬 Chen, D., Dong, L., Jiang, S., Li, W., Shi, J., Feng, X., Zhi, J., Tong, B., Li, M., Zheng, Q., Dong, Y.
📙 Sensors and Actuators B: Chemical, 2018, 255: 854–861
💉 Purpose: Efficient biomarker detection without sample separation steps.


5️⃣ 🔬 CO₂-Sensitive AIEgen for Analyzing Tumor-Stroma Interactions in Heterocellular Systems
🔍 Chen, D., Wang, H., Liu, P., Song, L., Shi, J., Tong, B., Dong, Y.
📗 Analytica Chimica Acta, 2018, 1001: 151–157
🧬 Focus: Understanding tumor microenvironment dynamics.


6️⃣ 🧿 A Novel Turn-on Fluorescent Probe for Intraoperative Diagnosis of Hepatocellular Carcinoma
🧪 Chen, D.#, Mao, H.#, Hong, Y., Tan, Y., Zhang, Y., Li, M., Dong, Y.
📕 Materials Chemistry Frontiers, 2020, 4: 2716–2722
🔎 Innovation: Rapid pathological differentiation during surgery using AIEgen derivatives.


7️⃣ 💡 A Simple “Spraying” Fluorescence-Guided Surgery for Liver Tumor Resection
🔬 Chen, D., Xiao, T., Wang, L., Chen, S., Kam, C., Zeng, G., Peng, L., Zhang, J., Li, M., Dong, Y.
📘 Aggregate, 2024, 5: e550
🧠 Impact: Introducing non-invasive, intraoperative tumor visualization via sprayable AIE probes.